Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Radiopharmaceuticals Market 2022 - By Type (Diagnostic, Therapeutic), By Application (Oncology, Cardiology, Neuroendocrinology, Nephrology, Musculoskeletal, Respiratory), By End-User(Hospitals and Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes ), And By Region, Opportunities And Strategies – Global Forecast To 2030

Radiopharmaceuticals Market 2022 - By Type (Diagnostic, Therapeutic), By Application (Oncology, Cardiology, Neuroendocrinology, Nephrology, Musculoskeletal, Respiratory), By End-User(Hospitals and Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes ), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 $3500.00 | Pages : 265 | Published : January 2022 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Radiopharmaceuticals Market Definition

The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in diagnosing and/or treating cancer, cardiovascular diseases, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes.

Radiopharmaceuticals, also known as nuclear medicine, are radioactive substances that are used in the scintigraphy technique, also known as a gamma scan, this is a diagnostic test in nuclear medicine, where radioisotopes attached to drugs that travel to intended organ or tissue are taken internally to create images of organs or tissues. A radiopharmaceutical is a molecule that consists of a radioisotope tracer attached to a pharmaceutical. After entering the body, the radio-labelled pharmaceutical will accumulate in a specific organ or tumor tissue. For delivering radioactivity directly to bones, bone scan imaging is used. The gamma rays released by the radioisotope can be detected by a medical instrument known as a gamma camera. Radiopharmaceuticals are agents that are used to diagnose and treat medical conditions. They can be administered to the patient through different routes of administration. They can be given orally, by injection, or by placing them in the eye or the bladder.

Book your 30 minutes free consultation with our research experts

Contact Us

Radiopharmaceuticals Market Size

The global radiopharmaceuticals market reached a value of nearly $4,290 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.0 % since 2015. The radiopharmaceuticals market is expected to grow from $4,290.0 million in 2020 to $5,716.3 million in 2025 at a compound annual growth rate (CAGR) of 5.9%. The radiopharmaceuticals market is then expected to grow at a CAGR of 5.6% from 2025 and reach $7,507.3 million in 2030.

Growth factors in the historic period include rise in healthcare expenditure, convenience of treatment, government initiatives, and changes in lifestyles. the market was restrained by restrictions in shorter shelf life, stringent regulatory framework, and lack of trained professionals.

Going forward increasing geriatric population, increasing prevalence of cancer and cardiovascular diseases, high capital investments, and new product launches will drive the growth in the radiopharmaceuticals market. factors that could hinder the growth of the market in the future include high costs, supply volatility and logistical difficulties, and coronavirus pandemic.

Radiopharmaceuticals Market Drivers

The key drivers of the radiopharmaceuticals market include:

Increasing Geriatric Population

Increasing aging population is expected to increase the prevalence of age-related ailments thus contributing to the growth of the radiopharmaceuticals market. The elderly population is increasing rapidly across the world, and it is expected to continue over the forecast period. By 2030, the population aged 65 years and above is expected to reach approximately 70 million in the USA. By 2050, the percentage of senior citizens in Japan is expected to grow to 40%. Due to the increasing life expectancy, the diagnosis of malignancy and treatment of elderly patients is becoming more common. Nowadays there are several available radiopharmaceuticals for elderly prostate cancer PET/CT imaging, each one with specific advantages and disadvantages. The two most promising and more widely employed in the clinical setting are 18F-Flucyclovine and 68Ga-PSMA.  In elderly prostate cancer patients, there may be advantages in radionuclides' ease of use and relative lack of toxicity compared with cytotoxic and cytostatic drugs. The expected increase in the aging population suffering from age-related ailments is expected to drive the radiopharmaceutical drugs market.

Radiopharmaceuticals Market Restraints

The key restraints on the radiopharmaceuticals market include:

High Costs

The high cost of radiopharmaceuticals is anticipated to limit the growth of the market. High costs and short half-life of radiopharmaceuticals are reducing their implementation in hospitals and clinics. The development cost of radiopharmaceuticals is very high compared to that of therapeutic drugs and also undergoes a very lengthy and expensive regulatory process. For instance, the cost of diagnostic radiopharmaceuticals development is $100 to $200 million for 8-10 years in comparison with the cost of pharmaceuticals, which ranges between $600 million to $1.2 billion for 10-12 years. Therefore, the high cost of radiopharmaceuticals is likely to act as a major restraint for market growth.

Radiopharmaceuticals Market Trends

Major trends influencing the radiopharmaceuticals market include:

Research Collaborations And Partnerships

Research collaborations and partnerships are gaining significant popularity in the radiopharmaceuticals market over recent years. Major companies operating in the radiopharmaceuticals market are collaborating with other industry players to conduct R&D activities to expand their business. For instance, in March 2020, Debiopharm, a Switzerland-based biopharmaceutical company, signed a research agreement with 3B Pharmaceuticals (3BP), a Germany-based biotechnology firm, to develop the Debio 0228 radioligand program, targeting the CAIX (Carbonic Anhydrase 9) enzyme to fight the progression of cancer.

Plant Capacity Expansion

Many companies in the radiopharmaceuticals market are adopting various strategic initiatives such as opening a new manufacturing facility and plant capacity expansion, which is gaining significant popularity. For instance, in May 2019, ITM Isotopen Technologien Munchen AG (ITM) announced the launch of its new manufacturing facility in the Munich, Germany to increase the production capacity of high-purity (n.c.a.) Lutetium-177 and no-carrier-added (n.c.a.) Lutetium-177 containing radiopharmaceuticals.  Lutetium-177 is popular under the brand EndolucinBeta and is an innovative isotope used in cancer therapy. This is the company’s step towards meeting the high demand for quality medical isotopes for precision oncology worldwide. The radiation used in Lutetium-177 is designed to only destroy the cancer cells. The expansion of theragnostic treatments, whereby the treatment becomes more personalized could lead to improved prognosis for cancer patients, companies in this market will strive to meet the demand.

Opportunities And Recommendations In The Radiopharmaceuticals Market

Opportunities –The top opportunities in the radiopharmaceuticals market segmented by type will arise in the therapeutic segment, which will gain $861.6 million of global annual sales by 2025. The top opportunities in the radiopharmaceuticals market segmented by application will arise in the oncology segment, which will gain $468.4 million of global annual sales by 2025. The top opportunities in the radiopharmaceuticals market segmented end user will arise in the diagnostic centers segment, which will gain $970.1 million of global annual sales by 2025. The radiopharmaceuticals market size will gain the most in the USA region at $479.9 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the radiopharmaceutical companies to focus on technological developments, investments in innovation, investment in artificial intelligence, radiopharmaceutical cancer therapy, expand in emerging markets, bundled payments, offer value-based pricing, increase adoption of internet and social media and visibility through websites, focus on collaborating with cancer treatment centers and partnerships with end-users.

Radiopharmaceuticals Market Segmentation

The radiopharmaceuticals market is segmented by type, by application, by end-user.
By Type –
The radiopharmaceuticals market is segmented by type into:
    • a) Diagnostic
    • b) Therapeutic
The diagnostic market was the largest segment of the radiopharmaceuticals market segmented by type, accounting for 59.8% of the total in 2020 and therapeutic segment is expected to be the fastest growing segment going forward, at a CAGR of 8.4% during 2020-2025.
By Application –
The radiopharmaceuticals market is segmented by application into:
    • a) Oncology
    • b) Cardiology
    • c) Neuroendocrinology
    • d) Nephrology
    • e) Musculoskeletal
    • f) Respiratory
    • g) Others
The oncology market was the largest segment of the radiopharmaceuticals market segmented by application, accounting for 28.3% of the total in 2020 and is expected to be the fastest growing segment going forward, at a CAGR of 6.74% during 2020-2025.
By End-User -
The radiopharmaceuticals market is segmented by end-user into:
    • a) Hospitals and Ambulatory Surgical Centers
    • b) Diagnostic Centers
    • c) Cancer Research Institutes
The diagnostic centers market was the largest segment of the radiopharmaceuticals market segmented by end user, accounting for 65.0% of the total in 2020 and is expected to be the fastest growing segment going forward, at a CAGR of 6.2% during 2020-2025.
By Geography - The radiopharmaceuticals market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the global radiopharmaceuticals market, accounting for 41.6% of the total in 2020. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the radiopharmaceuticals market will be South America, and Africa, where growth will be at CAGRs of 9.8% and 8.5% respectively. These will be followed by Middle East and Asia Pacific, where the markets are expected to grow at CAGRs of 8.2% and 6.4% respectively, during 2020-2025.

Radiopharmaceuticals Competitive Landscape

Major Competitors are:

  • Cardinal Health
  • Curium Pharma
  • Siemens Healthineers AG
  • Novartis AG
  • General Electric Company (GE)

    • Other Competitors Include:

  • IBA Group
  • Bayer AG
  • Lantheus Medical Imaging Inc.
  • Bracco Imaging S.p.A.
  • Eckert & Ziegler
  • Nihon Medi-Physics Co., Ltd.
  • Fujifilm Corporation
  • ANSTO
  • Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • Canon Inc.
  • China Isotope & Radiation Corporation (CIRC)
  • Advanced Accelerator Applications
  • JSC Isotope
  • Pharm-Sintez
  • Synektik SA
  • Polatom
  • RadioMedic sro
  • ÚJV Rež
  • Actinium Pharmaceuticals, Inc.
  • Alseres Pharmaceuticals, Inc.
  • Avid Radiopharmaceuticals
  • Cardinal Health, Inc.
  • Immunomedics, Inc.
  • Lantheus Medical Imaging Inc.
  • Nordion, Inc.
  • Fusion Pharmaceuticals
  • Peregrine Pharmaceuticals, Inc.
  • PETNET Solutions Inc.
  • Positron Corporation
  • Triad Isotopes, Inc.
  • Telix Pharmaceuticals
  • Rosatom
  • Alliance Medical Group
  • Hologic, Inc.
  • Segami Corporation
  • Novartis
  • IBA Molecuar Imaging
  • Eczacýbaþý-Monrol Nuclear Products
  • NTP Radioisotopes

      • Table Of Contents

      1. Radiopharmaceuticals Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Type

      6.3. Segmentation By Application

      6.4. Segmentation By End User

      7. Radiopharmaceuticals Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Type

      7.2.1. Diagnostic

      7.2.2. Therapeutic

      7.3. Segmentation By Application

      7.3.1. Oncology

      7.3.2. Cardiology

      7.3.3. Musculoskeletal

      7.3.4. Neuroendocrinology

      7.3.5. Respiratory

      7.3.6. Nephrology

      7.3.7. Others

      7.4. Segmentation By End-User

      7.4.1. Hospitals And Ambulatory Surgical Centers

      7.4.2. Diagnostic Centers

      7.4.3. Cancer Research Institutes

      8. Radiopharmaceuticals Market Trends And Strategies

      8.1. Research Collaborations And Partnerships

      8.2. Plant Capacity Expansion

      8.3. 3D Printing Technology

      8.4. Technological Developments

      8.5. Investments In Innovation

      8.6. In Silico Modeling

      8.7. Investment In Artificial Intelligence

      8.8. Dominance of Cardiology

      8.9. Radiopharmaceutical Cancer Therapy

      9. Impact Of COVID-19 On The Radiopharmaceuticals Market

      9.1. Introduction

      9.2. Impact On Laboratories And Procedures

      9.3. Impact On Inpatient And Outpatient Radiopharmaceutical Operations

      9.4. Supply and Demand Disruptions

      9.5. Conclusion

      10. Global Radiopharmaceuticals Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3.Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Radiopharmaceuticals Market Segmentation

      11.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12. Radiopharmaceuticals Market, Regional And Country Analysis

      12.1. Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.1.1. North America

      12.1.2. Asia Pacific

      12.1.3. Africa

      12.2. Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2.1. USA

      12.2.2. China

      13. Asia-Pacific Radiopharmaceuticals Market

      13.1. Asia-Pacific Radiopharmaceuticals Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4.Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6.Asia-Pacific Radiopharmaceuticals Market: Country Analysis

      13.7. China Radiopharmaceuticals Market

      13.8.China Radiopharmaceuticals Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. Background Information

      13.8.4. Government Initiatives

      13.8.5. Regulations

      13.8.6. Regulatory Bodies

      13.8.7. Major Associations

      13.8.8. Taxes Levied

      13.8.9. Corporate Tax Structure

      13.8.10. Investments

      13.8.11. Major Companies

      13.9.China Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.11. China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Radiopharmaceuticals Market

      13.14. India Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.16. India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Radiopharmaceuticals Market

      13.19. Japan Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.21. Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia Radiopharmaceuticals Market

      13.24. Australia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.26. Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia Radiopharmaceuticals Market

      13.29. Indonesia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.30. Indonesia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.31. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea Radiopharmaceuticals Market

      13.34. South Korea Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.35. South Korea Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.36. South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Radiopharmaceuticals Market

      14.1.Western Europe Radiopharmaceuticals Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory Bodies

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3.Western Europe Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Radiopharmaceuticals Market: Country Analysis

      14.7. UK Radiopharmaceuticals Market

      14.8. UK Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.10. UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany Radiopharmaceuticals Market

      14.13. Germany Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.15. Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France Radiopharmaceuticals Market

      14.18. France Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.20. France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Radiopharmaceuticals Market

      15.1. Eastern Europe Radiopharmaceuticals Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Radiopharmaceuticals Market: Country Analysis

      15.7. Russia Radiopharmaceuticals Market

      15.8. Russia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.10. Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Radiopharmaceuticals Market

      16.1.North America Radiopharmaceuticals Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate Tax Structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3.North America Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Radiopharmaceuticals Market: Country Analysis

      16.7. USA Radiopharmaceuticals Market

      16.8. USA Radiopharmaceuticals Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. Background Information

      16.8.4. Government Initiatives

      16.8.5. Regulations

      16.8.6. Regulatory Bodies

      16.8.7. Major Associations

      16.8.8. Taxes Levied

      16.8.9. Corporate Tax Structure

      16.8.10.Investments

      16.8.11. Major Companies

      16.9. USA Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.11. USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Radiopharmaceuticals Market

      17.1. South America Radiopharmaceuticals Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Radiopharmaceuticals Market: Country Analysis

      17.7. Brazil Radiopharmaceuticals Market

      17.8. Brazil Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.10. Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Radiopharmaceuticals Market

      18.1. Middle East Radiopharmaceuticals Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Investments

      18.1.10. Major Companies

      18.2. Middle East Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3.Middle East Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Radiopharmaceuticals Market

      19.1.Africa Radiopharmaceuticals Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes levied

      19.1.9. Investments

      19.1.10. Major Companies

      19.2. Africa Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3.Africa Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global Radiopharmaceuticals Market Competitive Landscape

      20.1. Company Profiles

      20.2. Cardinal Health

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Curium Pharma

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Siemens Healthineers AG

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Novartis AG

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. General Electric Company (GE)

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Radiopharmaceuticals Market Pipeline Analysis

      22. Key Mergers And Acquisitions In The Radiopharmaceuticals Market

      22.1. Bayer Acquired Noria Therapeutics And PSMA Therapeutics

      22.2. Curium Acquired MAP Medical Technologies Oy

      22.3. ISOLOGIC Acquired Diagnostic FDG Distribution From CPDC

      22.4. TTG Imaging Solutions Acquired NISotopes

      22.5. Curium Acquired MAP Medical Technologies Oy

      22.6. Progenics Acquired Orphan Radiopharmaceuticals

      22.7. Novartis Acquired Endocyte

      22.8. Jubilant Pharma Acquired Triad Isotopes

      22.9. Pharmalogic Acquired Radiopharmacy of Paducah

      22.10. IBA Molecular Acquired Mallinckrodt Nuclear Imaging

      23. Global Radiopharmaceuticals Market Opportunities And Strategies

      23.1. Global Radiopharmaceuticals Market In 2025 – Countries Offering Most New Opportunities

      23.2. Global Radiopharmaceuticals Market In 2025 – Segments Offering Most New Opportunities

      23.3.Global Radiopharmaceuticals Market In 2025 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. Radiopharmaceuticals Market, Conclusions And Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2. Place

      24.2.3. Price

      24.2.4. Promotion

      24.2.5. People

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      25.6. Copyright And Disclaimer

    List Of Tables

      Table 1: Global Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Asia-Pacific Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 14: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 15: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 16: Asia-Pacific Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 17: Asia-Pacific Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 18: Asia-Pacific Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 19: Asia-Pacific Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 20: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 21: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 22: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 23: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 24: China Healthcare Expenditure, 2015-2019, $ Billion
    • Table 25: China GDP Per Capita, 2015-2020, $
    • Table 26: China, Population By Age Group, 2015-2025, Thousands
    • Table 27: China Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 28: China Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 29: China Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 30: China Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 31: China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 32: China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 33: China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 34: China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 35: India Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 36: India Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 37: India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 38: India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 39: India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 40: India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 41: Japan Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 42: Japan Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 43: Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 44: Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 45: Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 46: Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 47: Australia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 48: Australia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 49: Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 50: Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 51: Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 52: Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 53: Indonesia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 54: Indonesia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 55: Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 56: Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 57: Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 58: Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 59: South Korea Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 60: South Korea Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 61: South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 62: South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 63: South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 64: South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 65: Western Europe Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 66: Western Europe GDP Per Capita, 2015-2020, $
    • Table 67: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 68: Western Europe Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 69: Western Europe Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 70: Western Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 71: Western Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 72: Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 73: Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 74: Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: UK Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 77: UK Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 78: UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 79: UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 80: UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 81: UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 82: Germany Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 83: Germany Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 84: Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 85: Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 86: Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: France Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 89: France Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 90: France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 91: France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 92: France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 93: France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 94: Eastern Europe Expenditure, By Country, 2015-2019, $ Billion
    • Table 95: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 96: Eastern Europe Population By Age Group, By Country, 2015-2025, Thousands
    • Table 97: Eastern Europe Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 98: Eastern Europe Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 99: Eastern Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 100: Eastern Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 101: Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 102: Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 103: Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 104: Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 105: Russia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 106: Russia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 107: Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 108: Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 109: Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 110: Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 111: North America Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 112: North America GDP Per Capita, 2015-2020, $
    • Table 113: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 114: North America Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 115: North America Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 116: North America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 117: North America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 118: North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 119: North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 120: North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 121: North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 122: USA Healthcare Expenditure, 2015-2019, $ Billion
    • Table 123: USA GDP Per Capita, 2015-2020, $
    • Table 124: USA, Population By Age Group, 2015-2025, Thousands
    • Table 125: USA Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 126: USA Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 127: USA Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 128: USA Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 129: USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 130: USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 131: USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 132: USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 133: South America Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 134: South America GDP Per Capita, 2015-2020, $
    • Table 135: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 136: South America Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 137: South America Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 138: South America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 139: South America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 140: South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 141: South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 142: South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 143: South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 144: Brazil Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 145: Brazil Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 146: Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 147: Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 148: Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 149: Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 150: Middle East Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 151: Middle East GDP Per Capita, 2015-2020, $
    • Table 152: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 153: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 154: Middle East Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 155: Middle East Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 156: Middle East Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 157: Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 158: Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 159: Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 160: Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 161: Africa Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 162: Africa GDP Per Capita, 2015-2020, $
    • Table 163: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 164: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 165: Africa Diagnostic Imaging Equipment Market Size, By Country, 2015-2025, $ Billion
    • Table 166: Africa Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Table 167: Africa Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 168: Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 169: Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 170: Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 171: Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 172: Global Radiopharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 173: Cardinal Health – Financial Overview, 2016 - 2020, $ Billion
    • Table 174: Siemens Healthineers AG – Financial Overview, 2016 - 2020, $ Billion
    • Table 175: Novartis AG – Financial Overview, 2016 – 2020, $ Billion
    • Table 176: General Electric Company (GE) – Financial Overview, 2016 - 2020, $ Billion
    • Table 177: Global Radiopharmaceuticals Market, Pipeline Analysis
    • Table 178: Global Radiopharmaceuticals Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 179: Global Radiopharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 180: Global Radiopharmaceuticals Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 181: Global Radiopharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 182: Radiopharmaceuticals - Market Data Sources

    List Of Figures

      Figure 1: Global Radiopharmaceuticals Market Segmentation By Type
    • Figure 2: Global Radiopharmaceuticals Market Segmentation By Application
    • Figure 3: Global Radiopharmaceuticals Market Segmentation By End User
    • Figure 4: Global Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: China Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 16: China Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: India Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 20: India Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Japan Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Japan Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Australia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Australia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Indonesia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 32: Indonesia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: South Korea Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 36: South Korea Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: Western Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 40: Western Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: UK Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 44: UK Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: Germany Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 48: Germany Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: France Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 52: France Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Eastern Europe Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Eastern Europe Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Russia Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Russia Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: North America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 64: North America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: USA Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 68: USA Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: South America Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 72: South America Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Brazil Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Brazil Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Middle East Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Middle East Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: Africa Radiopharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Africa Radiopharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 86: Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 87: Global Radiopharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 88: Cardinal Health – Financial Overview, 2016 – 2020, $ Billion
    • Figure 89: Siemens Healthineers AG – Financial Overview, 2016 – 2020, $ Billion
    • Figure 90: Novartis AG – Financial Overview, 2016 – 2020, $ Billion
    • Figure 91: General Electric Company (GE)  – Financial Overview, 2016 – 2020, $ Billion

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

    Read More

    Global Gene Therapy Market 2022 – Market Opportunities And Strategies

    Read More

    The Microbiome Market Share, Market Size, And Growth Rate 2022

    Read More

    Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

    Read More

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Protein Inhibitors Global Market Report 2024 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Enzymes Global Market Report 2024 – By Product Type (Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Frequently Asked Questions

    What is the definition of the radiopharmaceuticals market?

    Radiopharmaceuticals refer to a medication used to treat or diagnose diseases, including cancer, that contains a radioactive material. Likewise known as radioactive medication. These are the procedures used to identify certain illnesses or detect medical issues. The patient may receive them in a number of different ways. They could be injected, injected orally, or injected into the eye or bladder, for instance. For further insights on the radiopharmaceuticals market, request a sample here

    How will the radiopharmaceuticals market drivers and restraints affect the radiopharmaceuticals market dynamics? What forces will shape the radiopharmaceuticals industry going forward?

    The radiopharmaceuticals market growth is aided by increasing prevalence of cancer and cardiovascular diseases. However, some radiopharmaceuticals market restraints include high cost of radiopharmaceuticals. For further insights on the radiopharmaceuticals market, request a sample here

    What is the forecast market size or the forecast market value of the radiopharmaceuticals market?

    The radiopharmaceuticals market is expected to reach $8.25 billion in 2027 at a rate of 7.5%. For further insights on the radiopharmaceuticals market, request a sample here

    How is the radiopharmaceuticals market segmented?

    The global radiopharmaceuticals market is segmented as
    1) By Type: Diagnostic, Therapeutic, Other Types
    2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology, Nephrology, Other Applications
    3) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Other End Users
    For further insights on the radiopharmaceuticals market,     request a sample here

    Which region has the largest share of the radiopharmaceuticals market? What are the largest region's market size and growth rate?

    North America was the largest region in the radiopharmaceuticals market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

    Who are the major players in the radiopharmaceuticals market?

    Key competitors in the radiopharmaceuticals market are, Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Nordion Inc. (A Subsidiary of Sterigenics International), Mallinckrodt plc, Curium, Eckert & Ziegler, Eli Lilly, Eckert & Ziegler, IBA Group, Merck & Co. Inc., Philips Healthcare, Fujifilm Holding Corporation, Areva Pharma, Navidea Biopharmaceuticals Inc., Actinium Pharmaceuticals Inc., Global Medical Solutions LTD., Shine Medical Technologies. For further insights on the radiopharmaceuticals market, request a sample here.

    What are the key trends in the radiopharmaceuticals market?

    Major trends influencing the radiopharmaceuticals market include gaining popularity of research collaborations and partnerships. Major companies operating in the radiopharmaceuticals market are collaborating with other industry players to conduct R&D activities to expand their business. For further insights on the radiopharmaceuticals market, request a sample here.

    What are the major opportunities in the radiopharmaceuticals market? What are the strategies for the radiopharmaceuticals market?

    For detailed insights on the major opportunities and strategies in the radiopharmaceuticals market, request a sample here.

    How does the radiopharmaceuticals market relate to the overall economy and other similar markets?

    For detailed insights on radiopharmaceuticals market's relation to the overall economy and other similar markets, request a sample here.

    What are the latest mergers and acquisitions in the radiopharmaceuticals industry?

    For detailed insights on the mergers and acquisitions in the radiopharmaceuticals industry, request a sample here.

    What are the key dynamics influencing the radiopharmaceuticals market growth? SWOT analysis of the radiopharmaceuticals market.

    For detailed insights on the key dynamics influencing the radiopharmaceuticals market growth and SWOT analysis of the radiopharmaceuticals industry, request a sample here.